In fact, deleting Wnt5a from Ewing sarcoma cells by CRISPR-mediated gene editing phenocopies treatment with the pan-Wnt inhibitor, WNT974, providing direct mechanistic evidence that Wnt5a is a key driver of a pathway that is critical for Ewing sarcoma metastasis. This evidence concerns the gene WNT5A and Ewing sarcoma.